曲妥珠-话题@MedSci

#曲妥珠#

132篇内容 | 3544人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1648083, encodeId=4ca41648083e1, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=JCO：PTEN状态不影响乳腺癌患者从曲妥珠单抗治疗中获益, objectType=article, longId=19398, objectId=2320193980a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2320193980a, replyNumber=0, likeNumber=78, createdTime=2014-04-23, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2320193980a, moduleTitle=JCO：PTEN状态不影响乳腺癌患者从曲妥珠单抗治疗中获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2320193980a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648081, encodeId=46fc16480818e, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=JCO：贝伐单抗联合多西他赛及曲妥珠单抗不能改善乳腺癌患者无进展生存率, objectType=article, longId=17777, objectId=ebd21e777db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebd21e777db, replyNumber=0, likeNumber=87, createdTime=2013-09-10, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebd21e777db, moduleTitle=JCO：贝伐单抗联合多西他赛及曲妥珠单抗不能改善乳腺癌患者无进展生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebd21e777db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648080, encodeId=8cc11648080a1, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=Heart：曲妥珠单抗诱发心脏毒性反应临床常见, objectType=article, longId=14961, objectId=9e6414961d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e6414961d3, replyNumber=0, likeNumber=67, createdTime=2013-04-10, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e6414961d3, moduleTitle=Heart：曲妥珠单抗诱发心脏毒性反应临床常见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e6414961d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648084, encodeId=854a164808457, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=Lancet Oncol：12个月曲妥珠单抗治疗仍是HER2阳性早期乳腺癌患者的标准方案, objectType=article, longId=20927, objectId=f5f32092e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5f32092e78, replyNumber=0, likeNumber=90, createdTime=2013-12-01, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5f32092e78, moduleTitle=Lancet Oncol：12个月曲妥珠单抗治疗仍是HER2阳性早期乳腺癌患者的标准方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5f32092e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648082, encodeId=4368164808222, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案, objectType=article, longId=18507, objectId=75c41850e4b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75c41850e4b, replyNumber=0, likeNumber=0, createdTime=2013-12-07, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75c41850e4b, moduleTitle=Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75c41850e4b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648078, encodeId=5d0d16480e828, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=JNCI:蒽环类与曲妥珠单抗带来心脏衰竭风险, objectType=article, longId=9508, objectId=5d52950839, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d52950839, replyNumber=0, likeNumber=60, createdTime=2013-08-04, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d52950839, moduleTitle=JNCI:蒽环类与曲妥珠单抗带来心脏衰竭风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d52950839)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648079, encodeId=b2e816480e9bf, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=JCO：曲妥珠单抗治疗乳腺癌的CD风险较低, objectType=article, longId=10023, objectId=3300100235a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3300100235a, replyNumber=0, likeNumber=72, createdTime=2013-08-23, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3300100235a, moduleTitle=JCO：曲妥珠单抗治疗乳腺癌的CD风险较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3300100235a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648076, encodeId=7e6316480e6c4, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=hs-CRP示曲妥珠单抗心脏毒性, objectType=article, longId=5169, objectId=bbce5169e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbce5169e9, replyNumber=0, likeNumber=70, createdTime=2012-10-24, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbce5169e9, moduleTitle=hs-CRP示曲妥珠单抗心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbce5169e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648077, encodeId=3a8116480e7ee, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=hs-CRP示曲妥珠单抗心脏毒性, objectType=article, longId=5183, objectId=9bf5518387, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bf5518387, replyNumber=0, likeNumber=70, createdTime=2012-11-01, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bf5518387, moduleTitle=hs-CRP示曲妥珠单抗心脏毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bf5518387)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648075, encodeId=370916480e590, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=曲妥珠单抗Emtansine治疗乳腺癌III期研究结果公布, objectType=article, longId=4989, objectId=a170498967, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a170498967, replyNumber=0, likeNumber=79, createdTime=2012-08-02, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a170498967, moduleTitle=曲妥珠单抗Emtansine治疗乳腺癌III期研究结果公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a170498967)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648074, encodeId=b8bf16480e40c, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=NEJM：在HER2阳性乳腺癌中的曲妥珠单抗辅助治疗, objectType=article, longId=3189, objectId=acf73189d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acf73189d5, replyNumber=0, likeNumber=73, createdTime=2012-03-03, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acf73189d5, moduleTitle=NEJM：在HER2阳性乳腺癌中的曲妥珠单抗辅助治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acf73189d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1648073, encodeId=355316480e3d7, content=<a href='/topic/show?id=d5c560226fc' target=_blank style='color:#2F92EE;'>#曲妥珠#</a>, objectTitle=HER2阳性早期乳腺癌化疗后辅助曲妥珠单抗有益, objectType=article, longId=2441, objectId=3f03244110, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f03244110, replyNumber=0, likeNumber=74, createdTime=2011-08-06, rootId=0, userName=linlin2320, userId=a67b23554000, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f03244110, moduleTitle=HER2阳性早期乳腺癌化疗后辅助曲妥珠单抗有益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f03244110)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

曲妥珠

2020-05-29

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

JCO：PTEN状态不影响乳腺癌患者从曲妥珠单抗治疗中获益

2014-04-23

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

JCO：贝伐单抗联合多西他赛及曲妥珠单抗不能改善乳腺癌患者无进展生存率

2013-09-10

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

Heart：曲妥珠单抗诱发心脏毒性反应临床常见

2013-04-10

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

Lancet Oncol：12个月曲妥珠单抗治疗仍是HER2阳性早期乳腺癌患者的标准方案

2013-12-01

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

Lancet Oncol：帕妥珠单抗、曲妥珠单抗和多烯紫杉醇方案可作为HER2阳性的转移性乳腺癌患者的标准治疗方案

2013-12-07

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

JNCI:蒽环类与曲妥珠单抗带来心脏衰竭风险

2013-08-04

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

JCO：曲妥珠单抗治疗乳腺癌的CD风险较低

2013-08-23

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

hs-CRP示曲妥珠单抗心脏毒性

2012-10-24

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

hs-CRP示曲妥珠单抗心脏毒性

2012-11-01

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

曲妥珠单抗Emtansine治疗乳腺癌III期研究结果公布

2012-08-02

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

NEJM：在HER2阳性乳腺癌中的曲妥珠单抗辅助治疗

2012-03-03

linlin2320 (审核中...)

前往app查看评论内容

#曲妥珠#

HER2阳性早期乳腺癌化疗后辅助曲妥珠单抗有益

2011-08-06

科室
- - 订阅+
  - 更多科室
工具
服务